Moderna, Inc.
No trades
No trades
Price target
112.720.000.00%
The 18 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.
Analyst rating
Based on 25 analysts giving stock ratings in the past 3 months.
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise
This is not investment advice and doesn't take into account your personal circumstances. It isn't a recommendation to buy, sell, or hold any asset. See the Terms of Use and always do your own research.
Frequently asked questions
The current price of MRNA is 143.97 USD — it has increased by 5.38% in the past 24 hours. Watch Moderna, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Moderna, Inc. stocks are traded under the ticker MRNA.
MRNA stock has fallen by −6.28% compared to the previous week, the month change is a 137.65% rise, over the last year Moderna, Inc. has showed a 485.72% increase.
We've gathered analysts' opinions on Moderna, Inc. future price: according to them, MRNA price has a max estimate of 170.00 USD and a min estimate of 40.00 USD. Watch MRNA chart and read a more detailed Moderna, Inc. stock forecast: see what analysts think of Moderna, Inc. and suggest that you do with its stocks.
MRNA reached its all-time high on Aug 10, 2021 with the price of 497.49 USD, and its all-time low was 11.54 USD and was reached on Aug 7, 2019. View more price dynamics on MRNA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MRNA stock is 10.91% volatile and has beta coefficient of −0.07. Track Moderna, Inc. stock price on the chart and check out the list of the most volatile stocks — is Moderna, Inc. there?
Today Moderna, Inc. has the market capitalization of 57.48 B, it has increased by 5.63% over the last week.
Yes, you can track Moderna, Inc. financials in yearly and quarterly reports right on TradingView.
Moderna, Inc. is going to release the next earnings report on Oct 29, 2026. Keep track of upcoming events with our Earnings Calendar.
MRNA earnings for the last quarter are −1.97 USD per share, whereas the estimation was −2.03 USD resulting in a 3.06% surprise. The estimated earnings for the next quarter are −1.10 USD per share. See more details about Moderna, Inc. earnings.
Moderna, Inc. revenue for the last quarter amounts to 145.00 M USD, despite the estimated figure of 102.93 M USD. In the next quarter, revenue is expected to reach 894.99 M USD.
MRNA net income for the last quarter is −782.00 M USD, while the quarter before that showed −1.34 B USD of net income which accounts for 0.00% change. Track more Moderna, Inc. financial stats to get the full picture.
No, MRNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 13, 2026, the company has 4.7 K employees. See our rating of the largest employees — is Moderna, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Moderna, Inc. EBITDA is −3.08 B USD, and current EBITDA margin is −147.07%. See more stats in Moderna, Inc. financial statements.
Like other stocks, MRNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Moderna, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Moderna, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Moderna, Inc. stock shows the strong buy signal. See more of Moderna, Inc. technicals for a more comprehensive analysis.